Pioglitazone decreases coronary artery inflammation in impaired glucose tolerance and diabetes mellitus: Evaluation by FDG-PET/CT imaging

JACC: Cardiovascular Imaging

Volumn 6, Issue 11, 2013, Pages 1172-1182

  Nitta, Yoshikazu ^a   Tahara, Nobuhiro ^a   Tahara, Atsuko ^a   Honda, Akihiro ^a   Kodama, Norihiro ^a   Mizoguchi, Minori ^a   Kaida, Hayato ^a   Ishibashi, Masatoshi ^a   Hayabuchi, Naofumi ^a   Ikeda, Hisao ^a   Yamagishi, Sho Ichi ^a   Imaizumi, Tsutomu ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

18F fluorodeoxyglucose positron emission tomography; computed tomography angiography; coronary artery disease; high sensitivity C reactive protein; pioglitazone; vascular inflammation

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GLIMEPIRIDE; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; IOHEXOL; PIOGLITAZONE;

AGED; ANGIOGRAPHY DEVICE; ARTICLE; BLOOD CHEMISTRY; BOLUS INJECTION; CLINICAL ARTICLE; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DRUG DOSE TITRATION; DRUG EFFECT; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEART FAILURE; HEART INFARCTION; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; NON INSULIN DEPENDENT DIABETES MELLITUS; PET SCANNER; PRIORITY JOURNAL; RIGHT CORONARY ARTERY; SCINTISCANNING; VASCULITIS; WAIST CIRCUMFERENCE;

(18)F-FLUORODEOXYGLUCOSE; (18)F-FLUORODEOXYGLUCOSE-POSITRON EMISSION TOMOGRAPHY; COMPUTED TOMOGRAPHY; COMPUTED TOMOGRAPHY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CT; DIABETES MELLITUS; DM; FASTING PLASMA GLUCOSE; FDG; FPG; GLYCOSYLATED HEMOGLOBIN; HBA1C; HIGH-SENSITIVITY C-REACTIVE PROTEIN; HSCRP; IGT; IMPAIRED GLUCOSE TOLERANCE; INTERQUARTILE RANGE; IQR; LEFT MAIN TRUNK; LMT; PET; PIOGLITAZONE; POSITRON EMISSION TOMOGRAPHY; STANDARDIZED UPTAKE VALUE; SUV; TARGET-TO-BACKGROUND RATIO; TBR; VASCULAR INFLAMMATION;

AGED; BIOLOGICAL MARKERS; BLOOD GLUCOSE; C-REACTIVE PROTEIN; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY VESSELS; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FLUORODEOXYGLUCOSE F18; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; JAPAN; MALE; MIDDLE AGED; MULTIMODAL IMAGING; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; SULFONYLUREA COMPOUNDS; THIAZOLIDINEDIONES; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84888045303     PISSN: 1936878X     EISSN: 18767591     Source Type: Journal    
DOI: 10.1016/j.jcmg.2013.09.004     Document Type: Article

References (36)

1. J.J. Boyle Association of coronary plaque rupture and atherosclerotic inflammation J Pathol 181 1997 93 99
2. G. Pasterkamp, A.H. Schoneveld, and A.C. van der Wal Inflammation of the atherosclerotic cap and shoulder of the plaque is a common and locally observed feature in unruptured plaques of femoral and coronary arteries Arterioscler Thromb Vasc Biol 19 1999 54 58
3. A.C. van der Wal, A.E. Becker, C.M. van der Loos, and P.K. Das Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology Circulation 89 1994 36 44
4. N. Tahara, T. Imaizumi, R. Virmani, and J. Narula Clinical feasibility of molecular imaging of plaque inflammation in atherosclerosis J Nucl Med 50 2009 331 334
5. C. Laubenbacher, D. Saumweber, and C. Wagner-Manslau Comparison of fluorine-18-fluorodeoxyglucose PET, MRI and endoscopy for staging head and neck squamous-cell carcinomas J Nucl Med 36 1995 1747 1757
6. R.E. Coleman Value of FDG-PET scanning in management of lung cancer Lancet 359 2002 1361 1362
7. S. Nishizawa, S. Kojima, and S. Teramukai Prospective evaluation of whole-body cancer screening with multiple modalities including [18F] fluorodeoxyglucose positron emission tomography in a healthy population: a preliminary report J Clin Oncol 27 2009 1767 1773
8. Y. Kobayashi, K. Ishii, and K. Oda Aortic wall inflammation due to Takayasu arteritis imaged with 18F-FDG PET coregistered with enhanced CT J Nucl Med 46 2005 917 922
9. D. Tezuka, G. Haraguchi, and T. Ishihara Role of FDG PET-CT in Takayasu arteritis: sensitive detection of recurrences J Am Coll Cardiol Img 5 2012 422 429
10. K. Suda, N. Tahara, and Y. Kudo Persistent coronary arterial inflammation in a patient long after the onset of Kawasaki disease Int J Cardiol 154 2012 193 194
11. J.H. Rudd, E.A. Warburton, and T.D. Fryer Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography Circulation 105 2002 2708 2711
12. A. Tawakol, R.Q. Migrino, and G.G. Bashian In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients J Am Coll Cardiol 48 2006 1818 1824
13. N. Tahara, H. Kai, and M. Ishibashi Simvastatin attenuates plaque inflammation: evaluation by fluorodeoxyglucose positron emission tomography J Am Coll Cardiol 48 2006 1825 1831
14. N. Tahara, H. Kai, and S. Yamagishi Vascular inflammation evaluated by [18F]-fluorodeoxyglucose positron emission tomography is associated with the metabolic syndrome J Am Coll Cardiol 49 2007 1533 1539
15. N. Tahara, H. Kai, and H. Nakaura The prevalence of inflammation in carotid atherosclerosis: analysis with fluorodeoxyglucose-positron emission tomography Eur Heart J 28 2007 2243 2248
16. M. Mizoguchi, N. Tahara, and A. Tahara Pioglitazone attenuates atherosclerotic plaque inflammation in patients with impaired glucose tolerance or diabetes: a prospective, randomized, comparator-controlled study using serial FDG PET/CT imaging study of carotid artery and ascending aorta J Am Coll Cardiol Img 4 2011 1110 1118
17. K. Shinozaki, M. Suzuki, M. Ikebuchi, Y. Hara, and Y. Harano Demonstration of insulin resistance in coronary artery disease documented with angiography Diabetes Care 19 1996 1 7
18. T. Takagi, K. Yoshida, and T. Akasaka Hyperinsulinemia during oral glucose tolerance test is associated with increased neointimal tissue proliferation after coronary stent implantation in nondiabetic patients: a serial intravascular ultrasound study J Am Coll Cardiol 36 2000 731 738
19. S. Aronoff, S. Rosenblatt, S. Braithwaite for the Pioglitazone 001 Study Group Pioglitazone hydrochloride monotherapy improves glycemic control in the treatment of patients with type 2 diabetes: a 6-month randomized placebo-controlled dose-response study Diabetes Care 23 2000 1605 1611
20. J.A. Dormandy, B. Charbonnel, D.J. Eckland for the PROACTIVE Investigators Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROACTIVE Study (Prospective Pioglitazone Clinical Trial in Macrovascular Events): a randomised controlled trial Lancet 366 2005 1279 1289
21. R. Wilcox, M.G. Bousser, D.J. Betteridge for the PROACTIVE Investigators Effects of pioglitazone in patients with type 2 diabetes with or without previous stroke: results from PROACTIVE (Prospective Pioglitazone Clinical Trial in Macrovascular Events 04) Stroke 38 2007 865 873
22. E. Erdmann, J.A. Dormandy, B. Charbonnel for the PROACTIVE Investigators The effect of pioglitazone on recurrent myocardial infarction in 2,445 patients with type 2 diabetes and previous myocardial infarction: results from the PROACTIVE (PROACTIVE 05) study J Am Coll Cardiol 49 2007 1772 1780
23. T. Mazzone, P.M. Meyer, and S.B. Feinstein Effect of pioglitazone compared with glimepiride on carotid intima-media thickness in type 2 diabetes: a randomized trial JAMA 296 2006 2572 2581
24. S.E. Nissen, S.J. Nicholls, K. Wolski for the PERISCOPE Investigators Comparison of pioglitazone vs glimepiride on progression of coronary atherosclerosis in patients with type 2 diabetes: the PERISCOPE randomized controlled trial JAMA 299 2008 1561 1573
25. J. Wykrzykowska, S. Lehman, and G. Williams Imaging of inflamed and vulnerable plaque in coronary arteries with 18F-FDG PET/CT in patients with suppression of myocardial uptake using a low-carbohydrate, high-fat preparation J Nucl Med 50 2009 563 568
26. T. Saam, A. Rominger, and S. Wolpers Association of inflammation of the left anterior descending coronary artery with cardiovascular risk factors, plaque burden and pericardial fat volume: a PET/CT study Eur J Nucl Med Mol Imaging 37 2010 1203 1212
27. I.S. Rogers, K. Nasir, and A.L. Figueroa Feasibility of FDG imaging of the coronary arteries: comparison between acute coronary syndrome and stable angina J Am Coll Cardiol Img 3 2010 388 397
28. V.Y. Cheng, P.J. Slomka, and L. Le Meunier Coronary arterial 18F-FDG uptake by fusion of PET and coronary CT angiography at sites of percutaneous stenting for acute myocardial infarction and stable coronary artery disease J Nucl Med 53 2012 575 583
29. Y. Araki, H. Kumakura, and H. Kanai Prevalence and risk factors for cerebral infarction and carotid artery stenosis in peripheral arterial disease Atherosclerosis 223 2012 473 477
30. P. Libby Inflammation in atherosclerosis Nature 420 2002 868 874
31. B.D. Lamon, and D.P. Hajjar Inflammation at the molecular interface of atherogenesis: an anthropological journey Am J Pathol 173 2008 1253 1264
32. G.K. Hansson Inflammation, atherosclerosis, and coronary artery disease N Engl J Med 352 2005 1685 1695
33. N. Tahara, S. Yamagishi, and M. Takeuchi Positive association between serum level of glyceraldehyde-derived advanced glycation end products and vascular inflammation evaluated by 18F-fluorodeoxyglucose positron emission tomography Diabetes Care 35 2012 2618 2625
34. K. Chang, S.A. Francis, and E. Aikawa Pioglitazone suppresses inflammation in vivo in murine carotid atherosclerosis: novel detection by dual-target fluorescence molecular imaging Arterioscler Thromb Vasc Biol 30 2010 1933 1939
35. M. Joner, A. Farb, and Q. Cheng Pioglitazone inhibits in-stent restenosis in atherosclerotic rabbits by targeting transforming growth factor-beta and MCP-1 Arterioscler Thromb Vasc Biol 27 2007 182 189
36. W.M. Freitas, L.A. Quaglia, and S.N. Santos Association of systemic inflammatory activity with coronary and carotid atherosclerosis in the very elderly Atherosclerosis 216 2011 212 216